uses of at least one platelet activating factor (paf) derivative or platelet activating factor (paf) conjugate, and at least one antibody preparation, and methods for immunization and prophylaxis, prevention and treatment of a mammal, and diagnosis of the presence or absence of igm, igg or iga antibodies related to the increased or decreased risk of developing ischemic cardiovascular disease.
Low levels of antibodies reactive with a PAF-conjugate are related to an increased risk of developing cardiovascular diseases. Thus, compositions and methods of diagnosis and therapy for cardiovascular diseases are provided.
